Céline Gounder, KFF Health News’ editor-at-large for public health, discussed recommendations for covid-19 vaccinations for children on NPR’s “Morning Edition” on Aug. 20. Gounder then discussed the infant mortality crisis in Mississippi on CBS News’ “CBS Evening News Plus” on Aug. 22. She also discussed the resignation of top Centers for Disease Control and Prevention officials after…
Mental health experts are hopeful about the de-stigmatization of behavioral health, the promise of AI and other areas, they shared at a recent conference. The post 4 Areas Within Mental Health Care that Give Executives Hope appeared first on MedCity News.
As the federal government reworks rules for a $42 billion broadband expansion program, millions of Americans live in places where there aren’t enough health care providers and internet speeds aren’t good enough for telehealth. A KFF Health News analysis found people in these “dead zones” live sicker and die younger on average than their peers…
This brief provides an overview of vaccine coverage requirements by payer or program, as they relate to ACIP and the CDC.
Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly pledged to protect and improve health services for Native Americans — whether speaking during his late-January Senate confirmation hearing or an April trip to Arizona, where he met with tribal leaders. In some ways, he has. When layoffs were set to hit the Indian…
President-elect Donald Trump’s return to the White House could embolden Republicans who want to weaken or repeal the Affordable Care Act, but implementing such sweeping changes would still require overcoming procedural and political hurdles. Trump, long an ACA opponent, expressed interest during the campaign in retooling the health law. In addition, some high-ranking Republican lawmakers…
As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond. The post 2025 and Beyond: Key Trends to Watch in Pharmacy appeared first on MedCity News.
Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News.
Get Accurate Results with Blood Test at Home You need not wait several days for a doctor’s appointment or spend hours waiting at diagnostic labs. These modern test kits allow you to monitor important health markers right from your home, with accurate results delivered quickly and privately. Whether you’re keeping an eye on your cholesterol,…
Forget repeal and replace. Critics of the Affordable Care Act, a.k.a. Obamacare, have a new target: key parts of the law that they say are too costly and provide incentive for fraud. Topping that list are the ACA’s enhanced subsidies, put in place during the coronavirus pandemic as part of economic recovery legislation and set to…